MBL2 and hyperinsulinemic hypoglycemia, familial, 4: In an early RA study, Saevarsdottir et al found that MBL deficiency was a predictor of poor outcome characterized by erosive joint disease as determined by plain X-rays, reduced responsiveness to conventional synthetic DMARD therapy and higher concentrations of rheumatoid factor [10].